Philadelphia, PA (Oct. 6, 2020) – The Ñî¹óåú´«Ã½ (ACP) has issued Best Practice Advice aimed at simplifying and improving treatment of patients diagnosed with chronic hepatitis C virus (HCV). ACP is based on the World Health Organization Guideline and is authored by the ACP Scientific Medical Policy Committee and published in Annals of Internal Medicine.
Philadelphia, PA (Oct. 5, 2020) – In new , the Ñî¹óåú´«Ã½ (ACP) says that evidence points toward a net benefit with the use of remdesivir for patients with COVID-19. Should Remdesivir Be Used for the Treatment of Patients with COVID-19? Rapid, Living Practice Points from the Ñî¹óåú´«Ã½ (Version 1) was published today in Annals of Internal Medicine.
Statement attributable to:
Jacqueline W. Fincher, MD, MACP
President, Ñî¹óåú´«Ã½
ACP is pleased to announce that the Board of Regents has approved the following individuals and institutions to receive College awards and Mastership.
Washington, DC (September 15, 2020) — Today the Ñî¹óåú´«Ã½ (ACP) released a new policy paper focused on increasing competition in the marketplace and addressing anticompetitive behaviors to combat the rising costs of prescription drugs. The new paper titled , is the third installment of a series published in Annals of Internal Medicine.
Washington, DC (September 11, 2020) — Today the Ñî¹óåú´«Ã½ (ACP) sent a letter to every member of Congress stressing the importance that the planned increases in payments for evaluation and management (E/M) services and other changes to the Medicare Physician Fee Schedule move forward as scheduled on Jan. 1.
